Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Stye Relief is a homeopathic ophthalmic solution developed and manufactured by Similasan Corporation. It is designed for the temporary symptomatic relief of symptoms associated with styes (hordeolum), such as redness, burning, stinging, and itching. The formulation contains highly diluted active ingredients, including *Conium maculatum* (flowering top), *Graphites*, and *Sulfur*. As a homeopathic product, it is marketed over-the-counter (OTC) and has not been evaluated by the FDA for safety or efficacy. It does not treat the underlying bacterial infection of the eyelid glands but focuses on alleviating the associated discomfort.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Stye Relief.